Craparo Emanuela F, Cavallaro Gennara, Bondì Maria L, Mandracchia Delia, Giammona Gaetano
Dipartimento di Chimica e Tecnologie Farmaceutiche, Università di Palermo, via Archirafi, 32-90123 Palermo, Italy.
Biomacromolecules. 2006 Nov;7(11):3083-92. doi: 10.1021/bm060570c.
Nanoparticles with different surface PEGylation degree were prepared by using as starting material alpha,beta-poly(N-2-hydroxyethyl)-d,l-aspartamide (PHEA). PHEA was functionalized with a PEG amino-derivative for obtaining PHEA-PEG(2000) copolymer. Both PHEA and PHEA-PEG(2000) were derivatized with methacrylic anhydride (MA) for obtaining poly(hydroxyethylaspartamide methacrylated) (PHM) and poly(hydroxyethylaspartamide methacrylated)-PEGylated (PHM-PEG(2000)), respectively. Nanoparticles were obtained by UV irradiation of an inverse microemulsion, using as internal phase an aqueous solution of PHM alone or of the PHM/PHM-PEG(2000) mixture at different weight ratio and as external phase a mixture of propylene carbonate and ethyl acetate. Obtained nanoparticles were characterized by FT-IR analysis, dimensional analysis, and TEM micrography. XPS analysis and zeta potential measurements demonstrated the presence of PEG onto the nanoparticle surface. Moreover, the partial degradation of nanoparticles in the presence of esterase as a function of time was demonstrated. Finally, nanoparticles did not possess any cytotoxic activity against K-562 cells and were able to escape from phagocytosis depending on the surface PEGylation degree.
以α,β-聚(N-2-羟乙基)-d,l-天冬酰胺(PHEA)为起始原料制备了具有不同表面聚乙二醇化程度的纳米颗粒。PHEA用聚乙二醇氨基衍生物进行功能化,以获得PHEA-PEG(2000)共聚物。PHEA和PHEA-PEG(2000)均用甲基丙烯酸酐(MA)进行衍生化,分别得到聚(甲基丙烯酸羟乙基亚天冬酰胺)(PHM)和聚(甲基丙烯酸羟乙基亚天冬酰胺)-聚乙二醇化(PHM-PEG(2000))。通过对反相微乳液进行紫外线照射获得纳米颗粒,使用单独的PHM水溶液或不同重量比的PHM/PHM-PEG(2000)混合物作为内相,碳酸丙烯酯和乙酸乙酯的混合物作为外相。通过傅里叶变换红外光谱分析、尺寸分析和透射电子显微镜成像对所得纳米颗粒进行表征。X射线光电子能谱分析和ζ电位测量证明纳米颗粒表面存在聚乙二醇。此外,还证明了在酯酶存在下纳米颗粒随时间的部分降解情况。最后,纳米颗粒对K-562细胞不具有任何细胞毒性活性,并且能够根据表面聚乙二醇化程度逃避吞噬作用。